A. Aguado-martinez, G. Alvarez-garcia, I. Arnaiz-seco, E. Innes, and L. Ortega-mora, Use of avidity enzyme-linked immunosorbent assay and avidity Western blot to discriminate between acute and chronic Neospora caninum infection in cattle, J. Vet. Diagn. Investig, vol.17, pp.442-450, 2005.

M. Andersson, B. Wittgren, and K. Wahlund, Accuracy in multiangle light scattering measurements for molar mass and radius Model calculations and experiments, 2003.

G. Theillet, Virology, vol.529, pp.195-204, 2019.

, Anal. Chem, vol.75, pp.4279-4291

A. Baklouti, A. Goulet, J. Lichiere, B. Canard, R. N. Charrel et al., Toscana virus nucleoprotein oligomer organization observed in solution, Acta Crystallogr. Sect. D Struct. Biol, vol.73, pp.650-659, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01802854

E. Boura, D. Liebl, R. Spisek, J. Fric, M. Marek et al., Polyomavirus EGFP-pseudocapsids: analysis of model particles for introduction of proteins and peptides into mammalian cells, FEBS Lett, vol.579, pp.6549-6558, 2005.

C. Brouard, P. Bernillon, I. Quatresous, J. Pillonel, A. Assal et al., Estimated risk of Chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005.
URL : https://hal.archives-ouvertes.fr/hal-01817721

F. J. Burt, W. Chen, J. J. Miner, D. J. Lenschow, A. Merits et al., Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen, Lancet Infect. Dis, 2017.

L. Chang, K. A. Dowd, F. H. Mendoza, J. G. Saunders, S. Sitar et al., Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial, Lancet, vol.384, pp.2046-2052, 2014.

B. Cho, B. Y. Jeon, J. Kim, J. Noh, J. Kim et al., Expression and evaluation of Chikungunya virus E1 and E2 envelope proteins for serodiagnosis of Chikungunya virus infection, Yonsei Med. J, vol.49, pp.828-835, 2008.

Y. P. Chuan, Y. Y. Fan, L. Lua, and A. P. Middelberg, Quantitative analysis of virus-like particle size and distribution by field-flow fractionation, Biotechnol. Bioeng, vol.99, pp.1425-1433, 2008.

M. Conner, C. Zarley, B. Hu, S. Parsons, D. Drabinski et al., Virus-like particles as a rotavirus subunit vaccine, J. Infect. Dis, vol.174, pp.88-92, 1996.

D. M. Drake, R. K. Keswani, and D. W. Pack, Effect of serum on transfection by polyethylenimine/virus-like particle hybrid gene delivery vectors, Pharm. Res, vol.27, pp.2457-2465, 2010.

C. Fan, X. Ye, Z. Ku, L. Kong, Q. Liu et al., Beta-propiolactone inactivation of coxsackievirus A16 induces structural alteration and surface modification of viral capsids, J. Virol, vol.91, pp.38-55, 2017.

D. Fontana, M. Etcheverrigaray, R. Kratje, and C. Prieto, Development of rabies viruslike particles for vaccine applications: production, characterization, and protection studies, Methods Mol. Biol. (Clifton N.J.), vol.1403, pp.155-166, 2016.

L. Furuya-kanamori, S. Liang, G. Milinovich, R. J. Soares-magalhaes, A. C. Clements et al., IgG avidity in differential serodiagnosis of human strongyloidiasis active infection, BMC Infect. Dis, vol.16, pp.87-92, 2011.

W. Hammon, A. Rudnick, and G. E. Sather, Viruses associated with epidemic hemorrhagic fevers of the Philippines and Thailand, 1960.

M. B. Huglin and M. B. , Light Scattering From Polymer Solutions, pp.165-331, 1972.

J. Jose, J. E. Snyder, and R. J. Kuhn, A structural and functional perspective of alphavirus replication and assembly, Future Microbiol, vol.4, pp.837-856, 2009.

M. Khan, R. Dhanwani, J. S. Kumar, P. V. Rao, and M. Parida, Comparative evaluation of the diagnostic potential of recombinant envelope proteins and native cell culture purified viral antigens of Chikungunya virus, J. Med. Virol, vol.86, pp.1169-1175, 2014.

L. A. Koutsky, K. A. Ault, C. M. Wheeler, D. R. Brown, E. Barr et al., A controlled trial of a human papillomavirus type 16 vaccine, New Engl. J. Med, vol.347, pp.1645-1651, 2002.

N. Kushnir, S. J. Streatfield, and V. Yusibov, Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development, Vaccine, vol.31, pp.58-83, 2012.

T. A. Lamounier, L. M. De-oliveira, B. R. De-camargo, K. B. Rodrigues, E. F. Noronha et al., Production of Brazilian human norovirus VLPs and comparison of purification methods, Braz. J. Microbiol, vol.46, pp.1265-1268, 2015.

J. Li, Q. Zhang, S. Zhang, C. Li, Q. Liu et al., Virus-like particle-based immunoglobulin M capture enzyme-linked immunosorbent assay for the detection of IgM antibodies against Chikungunya virus. Bing. Du Xue Bao= Chin, J. Virol, vol.30, pp.599-604, 2014.

W. H. Lumsden, An epidemic of virus disease in Southern Province, Tanganyika Territory, II. Gen. Descr. Epidemiol, pp.1952-1953, 1955.

D. A. Martin, D. A. Muth, T. Brown, A. J. Johnson, N. Karabatsos et al., Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections, J. Clin. Microbiol, vol.38, pp.1823-1826, 2000.

R. B. Mcfee, Selected mosquito-borne illnesses-Chikungunya. Dis.-a-Mon, 2018.

S. W. Metz, J. Gardner, C. Geertsema, T. T. Le, L. Goh et al., Effective chikungunya virus-like particle vaccine produced in insect cells, PLoS Negl. Trop. Dis, vol.7, p.2124, 2013.

S. W. Metz and G. P. Pijlman, Production of Chikungunya Virus-Like Particles and Subunit Vaccines in Insect Cells, pp.297-309, 2016.

E. I. Minder, A. Schibli, D. Mahrer, P. Nesic, and K. Plüer, Effects of different centrifugation conditions on clinical chemistry and Immunology test results, BMC Clin. Pathol, vol.11, p.6, 2011.

B. Mishra, M. Sharma, S. K. Pujhari, R. K. Ratho, D. S. Gopal et al., Utility of multiplex reverse transcriptase-polymerase chain reaction for diagnosis and serotypic characterization of dengue and chikungunya viruses in clinical samples, Diagn. Microbiol. Infect. Dis, vol.71, pp.118-125, 2011.

N. Mishra, A. Caciula, A. Price, R. Thakkar, J. Ng et al., Diagnosis of zika virus infection by peptide array and enzyme-linked immunosorbent assay, 2018.

N. Noranate, N. Takeda, P. Chetanachan, P. Sittisaman, A. Nuegoonpipat et al., Characterization of chikungunya virus-like particles, PLoS One, vol.9, 2014.

L. K. Pattenden, A. P. Middelberg, M. Niebert, and D. I. Lipin, Towards the preparative and large-scale precision manufacture of virus-like particles, Trends Biotechnol, vol.23, pp.523-529, 2005.

L. F. Pease-3rd, D. I. Lipin, D. H. Tsai, M. R. Zachariah, L. H. Lua et al., Quantitative characterization of virus-like particles by asymmetrical flow field flow fractionation, electrospray differential mobility analysis, and transmission electron microscopy, Biotechnol. Bioeng, vol.102, pp.845-855, 2009.

P. Perrin and S. Morgeaux, Inactivation of DNA by beta-propiolactone, Biol.: J. Int. Assoc. Biol. Stand, vol.23, pp.207-211, 1995.

C. N. Peyrefitte, B. A. Pastorino, M. Bessaud, P. Gravier, F. Tock et al., Dengue type 3 virus, Emerg. Infect. Dis, vol.11, p.757, 2003.

H. Peyret, A protocol for the gentle purification of virus-like particles produced in plants, J. Virol. Methods, vol.225, pp.59-63, 2015.

S. Podzimek, Light Scattering, Size Exclusion Chromatography and Asymmetric Flow Field Flow Fractionation: Powerful Tools for the Characterization of Polymers, Proteins and Nanoparticles, 2011.

R. Priya, M. Khan, M. K. Rao, and M. Parida, Cloning, expression and evaluation of diagnostic potential of recombinant capsid protein based IgM ELISA for chikungunya virus, J. Virol. Methods, vol.203, pp.15-22, 2014.

P. Pushko, T. M. Tumpey, F. Bu, J. Knell, R. Robinson et al., Influenza viruslike particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice, Vaccine, vol.23, pp.5751-5759, 2005.

R. N. Qureshi and W. T. Kok, Application of flow field-flow fractionation for the characterization of macromolecules of biological interest: a review, Anal. Bioanal. Chem, vol.399, pp.1401-1411, 2011.

M. H. Rathore, J. Runyon, and T. U. Haque, Emerging Infectious Diseases, 2017.

M. C. Robinson, An epidemic of virus disease in Southern Province, Tanganyika Territory, I. Clin. Features, pp.1952-53, 1955.

V. Rougeron, I. C. Sam, M. Caron, D. Nkoghe, E. Leroy et al., Chikungunya, a paradigm of neglected tropical disease that emerged to be a new health global risk, J. Clin. Virol.: Off. Publ. Pan Am. Soc. Clin. Virol, vol.64, pp.144-152, 2015.

S. Saraswat, T. Athmaram, M. Parida, A. Agarwal, A. Saha et al., Expression and characterization of yeast derived Chikungunya virus like particles (CHIK-VLPs) and its evaluation as a potential vaccine candidate, PLoS Negl. Trop. Dis, vol.10, p.4782, 2016.

M. Schwameis, N. Buchtele, P. P. Wadowski, C. Schoergenhofer, and B. Jilma, Chikungunya vaccines in development, Hum. Vaccin. Immunother, vol.12, pp.716-731, 2016.

O. Schwartz and M. L. Albert, Biology and pathogenesis of chikungunya virus, Nat. Rev. Microbiol, vol.8, pp.491-500, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-00498486

E. M. Scolnick, A. A. Mclean, D. J. West, W. J. Mcaleer, W. J. Miller et al., Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA, JAMA, vol.251, pp.2812-2815, 1984.

H. Smolander, J. O. Koskinen, R. Vainionpää, N. J. Meltola, M. Lappalainen et al., A novel antibody avidity methodology for rapid point-of-care serological diagnosis, J. Virol. Methods, vol.166, pp.86-91, 2010.

A. Urakami, A. Sakurai, M. Ishikawa, M. L. Yap, Y. Flores-garcia et al., Development of a novel virus-like particle vaccine platform that mimics the immature form of alphavirus, Clin. Vaccin. Immunol, p.24, 2017.

M. Wagner, S. Holzschuh, A. Traeger, A. Fahr, and U. S. Schubert, Asymmetric flow field-flow fractionation in the field of nanomedicine, Anal. Chem, vol.86, pp.5201-5210, 2014.

J. Wu, C. Zhao, Q. Liu, W. Huang, and Y. Wang, Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system, Vaccine, vol.35, pp.6387-6394, 2017.

G. Yap, K. Y. Pok, Y. L. Lai, H. C. Hapuarachchi, A. Chow et al., Evaluation of Chikungunya diagnostic assays: differences in sensitivity of serology assays in two independent outbreaks, PLoS Negl. Trop, 2010.

G. Yohannes, M. Jussila, K. Hartonen, and M. L. Riekkola, Asymmetrical flow fieldflow fractionation technique for separation and characterization of biopolymers and bioparticles, J. Chromatogr. A, vol.1218, pp.4104-4116, 2011.